Skip to main content
. 2017 Oct 19;472(3):369–382. doi: 10.1007/s00428-017-2240-x

Table 1.

Patient characteristics

Number of patients All, n (%) Intestinal, n (%) Diffuse, n (%)
All 244 190 (77.9) 54 (22.1)
Median age at diagnosis (range)
72.3 (32.9–90.9) 74.4 (32.9–90.9) 66.8 (36.9–85.1)
Patient sex
 Female 101 (41.4) 68 (35.8) 33 (61.1)
 Male 143 (58.6) 122 (64.2) 21 (38.9)
Site of primary tumoura
 Distal oesophagus 19 (7.8) 19 (10.0)
 GOJ/cardia 60 (24.6) 60 (31.6)
 Corpus 106 (43.4) 52 (27.4)
 Antrum/pylorus 59 (24.2) 59 (31.1)
Tumour differentiation grade
 Grade 1 17 (7.0) 17 (8.9) 0 (0)
 Grade 2 93 (38.1) 93 (48.9) 0 (0)
 Grade 3 134 (54.9) 80 (42.1) 54 (100.0)
Stage
 I 46 (18.9) 40 (21.1) 6 (11.1)
 II 102 (41.8) 79 (41.6) 23 (42.6)
 III 83 (34.0) 61 (32.1) 22 (40.7)
 IV 13 (5.3) 10 (5.3) 3 (5.6)
Follow-up status
 Alive and free of disease 48 (19.7) 34 (17.9) 14 (25.9)
 Alive with disease 1 (0.4) 1 (0.5) 0 (0)
 Deceased 195 (79.9) 155 (81.6) 40 (74.1)

GOJ gastro-oesophageal junction

aDiffuse-type tumours are included in the tumours of the corpus